Exclusive Online Content
Mitsubishi Chemical to Bolster Technology Platform Through Acquisition of American Organic & Inorganic Hybrid Chemicals
Mitsubishi Chemical Corporation recently announced its subsidiary Mitsubishi Chemical America, Inc. has entered into a definitive agreement to acquire all of the issued and….
Trio Pharmaceuticals & Ajinomoto Bio-Pharma Services Enter Development Collaboration for a Novel Antibody Therapeutic
Trio Pharmaceuticals, Inc. and Ajinomoto Bio-Pharma Services recently announced a development collaboration agreement to evaluate AJICAP, a proprietary site-specific conjugation technology offered by…
Stevanato Group Announces Product Development Collaboration With Cambridge Design Partnership on Pen-Injector Technology
Stevanato Group, a leading producer of glass primary packaging and provider of integrated capabilities for combination products and Cambridge Design Partnership (CDP), a UK- and US-based leading technology and product design partner, recently….
Catalent Signs Agreement With Johnson & Johnson to be US Manufacturing Partner for Lead COVID-19 Vaccine Candidate
Catalent, Inc. recently announced a collaboration with the Janssen Pharmaceutical Companies of Johnson & Johnson, whereby Catalent’s Biologics business unit will accelerate availability of manufacturing capacity and…
PharmaCircle’s COVID-19 Coverage is Available to Everyone
Updated daily, coverage includes top line epidemiology, the current active pipeline, vaccine development, diagnostic tests, recent news and clinical trials.
Pivotal to Provide Specialized Clinical Research Services for New Clinical Trial With Patients That Have COVID-19
Pivotal recently announced it has been contracted to provide specialized clinical research services in a clinical trial to study the efficacy and safety of hyperimmune plasma, obtained from…
Histogen Announces Investigational Device Exemption Application
Histogen Inc. recently announced it has submitted an Investigational Device Exemption (IDE) application with the US FDA for the initiation of a….
Mogrify & Sangamo Announce Collaboration & Exclusive License Agreement
Mogrify Ltd and Sangamo Therapeutics recently announced they have executed a collaboration and exclusive license agreement for Sangamo to develop….
Mustang Bio Receives Advanced Therapy Medicinal Product Classification
Mustang Bio, Inc. recently announced that the European Medicines Agency (EMA) has granted Advanced Therapy Medicinal Product (ATMP) classification to….
Esperion Announces Development & Commercialization Agreement With Otsuka Pharmaceutical
Esperion recently announced it has entered into a collaboration agreement with Otsuka Pharmaceutical Co., Ltd. for the development and commercialization of….
Q BioMed Initiates Rapid Development of Novel COVID-19 Therapeutics
Q BioMed Inc. recently announced that together with its technology partner, Mannin Research, they are accelerating the rapid development of novel drugs for the treatment of life-threatening complications caused by COVID-19 and….
New COVID-19 Clinical Trial Supported by Octapharma USA
Octapharma USA is supporting a new investigator initiated clinical trial led by George Sakoulas, MD, of Sharp Memorial Hospital in San Diego, CA, focused on treating the most critical patients at the….
TFF Pharmaceuticals Announces R&D Collaboration for a Universal Influenza Vaccine
TFF Pharmaceuticals, Inc. recently announced that it has entered into a research collaboration with the University of Georgia’s Center for Vaccines and Immunology (CVI), along with….
HALIX Enters Collaboration for GMP Manufacturing of a COVID-19 Vaccine
HALIX B.V. has recently joined a consortium of partners under the guidance of the University of Oxford, to provide GMP manufacturing services supporting the large scale production of….
Samsung Bioepis Announces US Launch of Oncology Biosimilar for Early & Metastatic HER2-Overexpressing Breast Cancer & Metastatic Gastric Cancer
Samsung Bioepis Co., Ltd. recently announced today that ONTRUZANT (trastuzumab-dttb), a biosimilar of the reference biologic medicine HERCEPTIN (trastuzumab) for the treatment of….
Precision BioSciences Announces Dosing of First Patient in Phase 1/2a Clinical Trial
Precision BioSciences, Inc. recently announced the initiation of patient dosing in a Phase 1/2a clinical trial of its second off-the-shelf (allogeneic) chimeric….
OncoSec Collaborates With Providence Cancer Institute to Conduct First-in-Human Trial of Investigational Vaccine to Prevent COVID-19
OncoSec Medical Incorporated recently announced that Providence Cancer Institute, a part of Providence St. Joseph Health, is pursuing a first-in-human Phase 1 clinical trial of OncoSec’s novel….
Leading BioSciences Announces Potential for Investigational Drug to Treat Multiple Organ Dysfunction Syndrome in COVID-19 Patients
Leading BioSciences recently announced it has developed a potential approach to treat COVID-19 patients suffering from acute respiratory distress syndrome (ARDS) and multiple organ dysfunction syndrome (MODS) using its….
Beam Therapeutics Licenses SIRION Biotech’s LentiBOOST Technology
SIRION Biotech GmbH recently announced that Beam Therapeutics licensed rights to use SIRION Biotech’s LentiBOOST for use in….
COVID-19 Therapeutics: Summary of Recently Published Clinical Study using Hydroxychloroquine
Hydroxychloroquine sulphate (Plaquenil) an analog of chloroquine has an established track record for treating malaria and has demonstrated in vitro activity against the SARS-CoV and therefore …..
